Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Fate Therapeutics
AstraZeneca
M.D. Anderson Cancer Center
Nurix Therapeutics, Inc.
Merck Sharp & Dohme LLC
Sun Yat-sen University
AIDS Malignancy Consortium
Roswell Park Cancer Institute